Organization · Other
adMare BioInnovations
adMare BioInnovations is a Canadian organization established in 2019, focused on enhancing the life sciences sector. It operates from multiple locations, including Vancouver, Toronto, and Montreal, providing expertise, infrastructure, and seed investments to support the commercialization of academic research.
Overview
What adMare BioInnovations does
What adMare BioInnovations is
adMare BioInnovations is a Canadian organization established in 2019, focused on enhancing the life sciences sector. It operates from multiple locations, including Vancouver, Toronto, and Montreal, providing expertise, infrastructure, and seed investments to support the commercialization of academic research.
How it participates in the startup ecosystem
The current public profile supports funder and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder · Publisher
- Last reviewed
- March 19, 2026
Official channels
Find adMare BioInnovations elsewhere
Open the official website or a supported primary organization account.
Capability profile
adMare BioInnovations as a funder
Investment thesis
adMare BioInnovations aims to enhance the life sciences sector in Canada by building strong companies and fostering innovation ecosystems.
Focus narrative
adMare BioInnovations invests in and supports companies at various stages of development within the life sciences sector. Its focus includes translating academic research into commercial ventures, providing integrated services for therapeutic development, and fostering innovation ecosystems across Canada. The organization emphasizes collaboration with government, academia, and industry partners.
Value beyond capital
adMare BioInnovations provides integrated services for therapeutic development, access to specialized R&D infrastructure, and seed capital to support the growth of life sciences companies.
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series B · Series C · Growth Equity
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 38
Portfolio context
adMare has helped build 38 companies, of which 25 are still active. These companies have collectively raised approximately $2.4 billion in risk capital and have a combined value of around $5.7 billion. Notable portfolio companies include 26 Therapeutics, which focuses on therapies for dry eye disease; Kainova Therapeutics, developing immuno-oncology and inflammation therapies; Abdera Therapeutics, engaged in innovative therapeutic development; and Bellus Health, which works on treatments for chronic cough and other conditions.
Capability profile
adMare BioInnovations as a publisher
Editorial focus
adMare BioInnovations is dedicated to building strong life sciences companies and ecosystems in Canada. The organization focuses on translating academic research into commercial ventures, providing integrated services for therapeutic development, and fostering innovation ecosystems through collaboration with government, academia, and industry partners.
Audience value
adMare BioInnovations offers scientific and commercial expertise, specialized R&D infrastructure, and seed capital to support the development of life sciences companies and talent in Canada.
Format and cadence
- Content formats
- newsletter
- Cadence
- quarterly
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Students · Researchers
- Sectors
- Biotech & Life Sciences
- Regions
- CanadaNorth America
Flagship work and coverage
Flagship properties
adMare publishes a quarterly newsletter to keep stakeholders informed about news and events in the life sciences sector.
Common questions
What to know about adMare BioInnovations
Upseed classifies adMare BioInnovations under the Other organization type. Its current public profile includes funder and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 19, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.